OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improved relapse recovery in paediatric compared to adult multiple sclerosis
Tanuja Chitnis, Greg Aaen, Anita Belman, et al.
Brain (2020) Vol. 143, Iss. 9, pp. 2733-2741
Open Access | Times Cited: 62
Tanuja Chitnis, Greg Aaen, Anita Belman, et al.
Brain (2020) Vol. 143, Iss. 9, pp. 2733-2741
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
Myelin-oligodendrocyte glycoprotein antibody-associated disease
Romain Marignier, Yael Hacohen, Álvaro Cobo‐Calvo, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 9, pp. 762-772
Open Access | Times Cited: 402
Romain Marignier, Yael Hacohen, Álvaro Cobo‐Calvo, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 9, pp. 762-772
Open Access | Times Cited: 402
How patients with multiple sclerosis acquire disability
Fred Lublin, Dieter A. Häring, Habib Ganjgahi, et al.
Brain (2022) Vol. 145, Iss. 9, pp. 3147-3161
Open Access | Times Cited: 296
Fred Lublin, Dieter A. Häring, Habib Ganjgahi, et al.
Brain (2022) Vol. 145, Iss. 9, pp. 3147-3161
Open Access | Times Cited: 296
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
Nicola Capasso, Eleonora Virgilio, Antonio Covelli, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 26
Nicola Capasso, Eleonora Virgilio, Antonio Covelli, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 26
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Sifat Sharmin, Izanne Roos, Charles B. Malpas, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 5, pp. 348-357
Closed Access | Times Cited: 14
Sifat Sharmin, Izanne Roos, Charles B. Malpas, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 5, pp. 348-357
Closed Access | Times Cited: 14
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
Dejan Jakimovski, Samreen Awan, Svetlana Eckert, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 45-59
Open Access | Times Cited: 50
Dejan Jakimovski, Samreen Awan, Svetlana Eckert, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 45-59
Open Access | Times Cited: 50
Ocrelizumab in pediatric multiple sclerosis
Ceren Bibinoğlu Amirov, Sema Saltık, Cengiz Yalçınkaya, et al.
European Journal of Paediatric Neurology (2023) Vol. 43, pp. 1-5
Closed Access | Times Cited: 21
Ceren Bibinoğlu Amirov, Sema Saltık, Cengiz Yalçınkaya, et al.
European Journal of Paediatric Neurology (2023) Vol. 43, pp. 1-5
Closed Access | Times Cited: 21
Cognitive Issues in Pediatric Multiple Sclerosis
Emilio Portaccio, Ermelinda De Meo, Angelo Bellinvia, et al.
Brain Sciences (2021) Vol. 11, Iss. 4, pp. 442-442
Open Access | Times Cited: 34
Emilio Portaccio, Ermelinda De Meo, Angelo Bellinvia, et al.
Brain Sciences (2021) Vol. 11, Iss. 4, pp. 442-442
Open Access | Times Cited: 34
Diagnosis and treatment of progressive multiple sclerosis: A position paper
Carlo Pozzilli, Maura Pugliatti, Patrick Vermersch, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 1, pp. 9-21
Open Access | Times Cited: 23
Carlo Pozzilli, Maura Pugliatti, Patrick Vermersch, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 1, pp. 9-21
Open Access | Times Cited: 23
Multiple Sclerosis Progression and Relapse Activity in Children
Pietro Iaffaldano, Emilio Portaccio, Giuseppe Lucisano, et al.
JAMA Neurology (2023) Vol. 81, Iss. 1, pp. 50-50
Closed Access | Times Cited: 16
Pietro Iaffaldano, Emilio Portaccio, Giuseppe Lucisano, et al.
JAMA Neurology (2023) Vol. 81, Iss. 1, pp. 50-50
Closed Access | Times Cited: 16
Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach
Angelo Ghezzi
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 949-963
Open Access | Times Cited: 5
Angelo Ghezzi
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 949-963
Open Access | Times Cited: 5
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
Joachim Havla, Thivya Pakeerathan, Carolin Schwake, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 31
Joachim Havla, Thivya Pakeerathan, Carolin Schwake, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 31
Pediatric Multiple Sclerosis
Alexandra B. Kornbluh, Ilana Kahn
Seminars in Pediatric Neurology (2023) Vol. 46, pp. 101054-101054
Closed Access | Times Cited: 12
Alexandra B. Kornbluh, Ilana Kahn
Seminars in Pediatric Neurology (2023) Vol. 46, pp. 101054-101054
Closed Access | Times Cited: 12
Efficacy and safety of disease-modifying therapies in pediatric-onset multiple sclerosis: A systematic review of clinical trials and observational studies
Katarzyna Śladowska, Paweł Moćko, Tomasz Brzostek, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106263-106263
Closed Access
Katarzyna Śladowska, Paweł Moćko, Tomasz Brzostek, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106263-106263
Closed Access
La sclérose en plaques de l’enfant en pratique : mécanismes, diagnostic et approches thérapeutiques
Naïl Benallegue, Kumaran Deiva
Perfectionnement en Pédiatrie (2025)
Open Access
Naïl Benallegue, Kumaran Deiva
Perfectionnement en Pédiatrie (2025)
Open Access
Multiple sclerosis diagnosis: free light chain testing as a possible valuable marker in cerebrospinal fluid
Cristina Montarolo, Lara Calcagno, Simona Martinotti, et al.
Working Paper of Public Health (2025) Vol. 13
Open Access
Cristina Montarolo, Lara Calcagno, Simona Martinotti, et al.
Working Paper of Public Health (2025) Vol. 13
Open Access
Dilemmas in the differential diagnosis of pediatric multiple sclerosis
Jelena Drulović, Jasna Jančić, Blažo Nikolić, et al.
Medicinska istrazivanja (2025) Vol. 58, Iss. 1, pp. 75-81
Closed Access
Jelena Drulović, Jasna Jančić, Blažo Nikolić, et al.
Medicinska istrazivanja (2025) Vol. 58, Iss. 1, pp. 75-81
Closed Access
Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom
Omar Abdel‐Mannan, Celeste Manchoon, Thomas Rossor, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 4
Open Access | Times Cited: 27
Omar Abdel‐Mannan, Celeste Manchoon, Thomas Rossor, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 4
Open Access | Times Cited: 27
Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia and Epilepsy
Yixin Zhan, Shijia Chen, Zhenghan Jin, et al.
Neurology Genetics (2025) Vol. 11, Iss. 1
Closed Access
Yixin Zhan, Shijia Chen, Zhenghan Jin, et al.
Neurology Genetics (2025) Vol. 11, Iss. 1
Closed Access
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis
Ermelinda De Meo, Massimo Filippi, Maria Trojano, et al.
Annals of Neurology (2022) Vol. 91, Iss. 4, pp. 483-495
Closed Access | Times Cited: 15
Ermelinda De Meo, Massimo Filippi, Maria Trojano, et al.
Annals of Neurology (2022) Vol. 91, Iss. 4, pp. 483-495
Closed Access | Times Cited: 15
Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
Marcus Koch, Ester Moral, Luís Brieva, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1776-1785
Open Access | Times Cited: 8
Marcus Koch, Ester Moral, Luís Brieva, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1776-1785
Open Access | Times Cited: 8
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication
Monica Margoni, Paolo Preziosa, Maria A. Rocca, et al.
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 5, pp. 393-403
Closed Access | Times Cited: 14
Monica Margoni, Paolo Preziosa, Maria A. Rocca, et al.
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 5, pp. 393-403
Closed Access | Times Cited: 14
Preventing Multiple Sclerosis: The Pediatric Perspective
Duriel Hardy, Tanuja Chitnis, Emmanuelle Waubant, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 13
Duriel Hardy, Tanuja Chitnis, Emmanuelle Waubant, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 13
Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
Angelo Ghezzi, Rinze F. Neuteboom
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1867-1881
Open Access | Times Cited: 7
Angelo Ghezzi, Rinze F. Neuteboom
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1867-1881
Open Access | Times Cited: 7
A new look at cognitive functioning in pediatric MS
Lauren Krupp, Emmanuelle Waubant, Michael Waltz, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 1, pp. 140-149
Closed Access | Times Cited: 12
Lauren Krupp, Emmanuelle Waubant, Michael Waltz, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 1, pp. 140-149
Closed Access | Times Cited: 12
Interrogating large multiple sclerosis registries and databases: what information can be gained?
Maria Trojano, Tomáš Kalinčík, Pietro Iaffaldano, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 271-277
Open Access | Times Cited: 11
Maria Trojano, Tomáš Kalinčík, Pietro Iaffaldano, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 271-277
Open Access | Times Cited: 11
